HOME Press Releases Microarray Analysis Market worth $5.52 billion by 2023



Microarray Analysis Market worth $5.52 billion by 2023


The report "Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecast to 2023", The microarray analysis market is expected to reach USD 5.52 billion by 2023 from USD 3.82 billion in 2018, at a CAGR of 7.6%.

Browse 63 market data Tables and 31 Figures spread through 115 Pages and in-depth TOC on "Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecast to 2023"
https://www.marketsandmarkets.com/Market-Reports/microarray-analysis-market-55253403.html
Early buyers will receive 10% customization on reports.

The increasing incidence of cancer, growth in funding for genomic and proteomic research, and growing application areas of microarrays are major factors driving the growth of the microarray analysis market.

Consumables are expected to account for the largest market share in 2018

On the basis of product and services, the microarray analysis market is segmented into consumables, software and services, and instruments. In 2018, the consumables segment is expected to account for the largest share of the global microarray analysis market. The large share of this market segment can be attributed to the growing applications of microarray in various fields and the regular, repeated, & bulk purchases of consumables.

DNA microarray is estimated to account for the largest share of the microarray analysis market in 2018

By type, the microarray analysis market has been segmented into DNA microarrays, protein microarrays, and other microarrays. In 2018, the DNA microarrays segment is expected to account for the largest share of the microarray analysis market due to the use of DNA microarrays in various applications such as drug discovery, genomic and cancer research, personalized medicine, and genetic disease diagnosis.

The drug discovery segment is estimated to grow at the highest CAGR during the forecast period

The application segment is further segmented into research applications, drug discovery, disease diagnostics, and other applications. The drug discovery segment is estimated to register the highest CAGR during the forecast period. Microarrays analysis has multiple applications in drug discovery. It helps to measure the expression patterns of thousands of genes to identify appropriate targets for therapeutic intervention. Microarrays are also an integral part of therapeutic drug discovery, optimization, and clinical validation as they help to prioritize a few genes as potential therapeutic targets.

North America is estimated to command the largest share of the market in 2018

Based on region, the microarray analysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share of the global microarray analysis market. The increasing incidence of cancer and genetic diseases along with growth in the funding made available for genomics and proteomics research in this region are key factors supporting the growth of the microarray analysis market in North America.

Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

We will organize an analyst call and demonstrate the latent opportunities and threats which will likely impact your business, at no cost.

Speak to Analyst


* Name :
* Business Email :
* Phone :
* Designation :
* Country:
Report BT 6510: Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecast to 2023
* Enter the text from the image
   to the textbox :
5 6 9 1 4  
Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports